Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peter S. Chung"'
Autor:
Eunjin Hong, Eugeniu Carmanov, Alan Shi, Peter S. Chung, Adupa P. Rao, Kevin Forrester, Paul M. Beringer
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1438 (2023)
Elexacaftor/tezacaftor/ivacaftor (ETI) treatment has potential benefits in lung transplant recipients, including improvements in extrapulmonary manifestations, such as gastrointestinal and sinus disease; however, ivacaftor is an inhibitor of cytochro
Externí odkaz:
https://doaj.org/article/5554101f956f44a4aaf97ee484c7fd66
Autor:
Eunjin Hong, Regina Li, Alan Shi, Lisa M. Almond, Joshua Wang, Amin Z. Khudari, Soumar Haddad, Sarkis Sislyan, Marissa Angelich, Peter S. Chung, Adupa P. Rao, Paul M. Beringer
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:291-299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::314951fb4c28a46424a25ec52bce3c26
https://doi.org/10.1002/phar.2786
https://doi.org/10.1002/phar.2786
Publikováno v:
Clinical pharmacology and therapeutics. 111(6)
Cystic fibrosis transmembrane conductance regulator (CFTR) modulating therapies, including elexacaftor-tezacaftor-ivacaftor, are primarily eliminated through cytochrome P450 (CYP) 3A-mediated metabolism. This creates a therapeutic challenge to the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a947c2bcb49cb91b6ab88fc5a38a30ea
https://pubmed.ncbi.nlm.nih.gov/35292968
https://pubmed.ncbi.nlm.nih.gov/35292968
Autor:
Peter S. Chung
Publikováno v:
Atlantic Economic Journal. 4:41-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f88e9b0095ca034f6eb7c8f1baed85a
https://doi.org/10.1007/bf02302156
https://doi.org/10.1007/bf02302156
Autor:
Peter S. Chung
Publikováno v:
The Journal of Financial and Quantitative Analysis. 9:1009
In the past most of the studies whose aim was to explain earnings-to-price ratios (or alternatively, price-earnings ratios) of common stocks attempted to answer the much-debated question raised in both investment and academic circles: Why does a give
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9147ce28885e520eebfa93bfaca8914
https://doi.org/10.2307/2329732
https://doi.org/10.2307/2329732